Tenaya Therapeutics Inc

NASDAQ:TNYA   3:10:40 PM EDT
3.38
+0.14 (+4.32%)
Products

Tenaya Therapeutics Announces FDA Clearance Of Investigational New Drug Application

Published: 09/06/2022 12:35 GMT
Tenaya Therapeutics Inc (TNYA) - Tenaya Therapeutics Announces FDA Clearance of Investigational New Drug Application and Initiation of Phase 1 Safety Study for Tn-301, an Hdac6 Inhibitor for Heart Failure With Preserved Ejection Fraction.
Tenaya Therapeutics Inc - Initiated Its First-in-human Phase 1 Clinical Trial of Tn-301 in Healthy Adult Participants.